We rarely, yet  selectively use concurrent capecitabine radiation therapy (CCRT) for management of breast cancer. A couple of instances we would consider using concurrent capecitabine at radio-sensitizing dose is when we have to treat bulky local-regional disease with radiation. We make a conse...